STOCK TITAN

PROFUSA INC WTS (NVACW) Financials

NVACW
FY2025 annual
Revenue Not reported for FY2025
EPS (Diluted) -$107.01 YoY not available
Free Cash Flow -$16.3M YoY not available
Operating Cash Flow -$16.2M n/m YoY
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 19, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the NVACW SEC filings page.

This page shows PROFUSA INC WTS (NVACW) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI NVACW FY2025

Profusa’s reported profile is development-led, cash-consuming, and financed with liabilities exceeding its asset base.

The 2025 operating cash flow of -$16.2M nearly matched free cash flow of -$16.3M, indicating that reported cash use was overwhelmingly operational rather than driven by capital investment.

The company’s financial profile remains development-stage: R&D rose from $1.6M in FY2024 to $2.8M in FY2025, while FY2025 revenue was unreported. Spending therefore remains oriented toward development rather than a documented commercial revenue base.

Liabilities fell from $122.3M in FY2024 to $30.4M in FY2025, reducing the reported obligation total but not eliminating the structural deficit. FY2025 assets of $3.8M were outweighed by negative equity of -$26.7M; the 0.2x current ratio also indicates current assets remained below current liabilities.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

PROFUSA INC WTS does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The metrics below are current.

Key Financial Metrics

Export CSV

Earnings & Revenue

EPS (Diluted)
-$151.80

PROFUSA INC WTS earned -$151.80 per diluted share (EPS) in Q2 2026.

Revenue

Not reported for Q2 2026.

EBITDA

Not reported for Q2 2026.

Net Income

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow
-$2.7M
QoQn/m

PROFUSA INC WTS recorded an outflow of $2.7M in free cash flow in Q2 2026, representing a cash shortfall after capex. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Debt
$719K
YoY+1743.6%
QoQ+91.7%

PROFUSA INC WTS held $719K in cash as of Q2 2026; no long-term debt figure is on record for that period.

Shares Outstanding
605,647

PROFUSA INC WTS had 605,647 shares outstanding in Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

None of these metrics is reported for Q2 2026.

Capital Allocation

R&D Spending
$823K
YoY+109.4%
QoQ-28.2%

PROFUSA INC WTS invested $823K in research and development in Q2 2026. This represents an increase of 109.4% from the same quarter a year earlier. Against the prior quarter it is down 28.2%.

Capital Expenditures
$73K
QoQ+1360.0%

PROFUSA INC WTS invested $73K in capex in Q2 2026, funding long-term assets and infrastructure. Against the prior quarter it is up 1360.0%.

Share Buybacks

Not reported for Q2 2026.

NVACW Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NVACW quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'24S-1/AQ3'2410-Q
RevenueN/AN/AN/AN/AN/AN/AN/A$75K
R&D Expenses$823K+109.4%$1.1M+164.1%N/A$722K+75.7%$393K$434KN/A$411K
SG&A Expenses$1.7M+182.3%$2.9M+188.9%N/A$21.0M+2636.2%$610K$990KN/A$767K
Operating Income-$2.5Mn/m-$4.0Mn/mN/AN/A-$1.0Mn/m-$1.4Mn/mN/A-$1.1Mn/m
Interest Expense$21K-96.5%$18K-96.4%N/A$169K-84.2%$600K$500KN/A$1.1M
Income TaxN/AN/AN/AN/A$2K-89.6%$19K-9.8%N/A$19K-23.5%
Net IncomeN/A-$3.5Mn/mN/AN/A-$2.3Mn/m-$2.7Mn/mN/A-$2.5Mn/m
EPS (Basic)-$151.80-$2.05-$104.72n/m-$0.70-$9100.78-$105.09-$1.28-3300.0%-$1.29
EPS (Diluted)-$151.80-$2.05-$104.72n/m-$0.70-$9100.78-$105.09-$1.28-4366.7%-$1.29
Diluted Shares (Avg)57,6762MN/A32M25825,844N/A2M

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, EBITDA.

NVACW Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NVACW quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'24S-1/AQ3'2410-Q
Total Assets$1.0M-46.9%$862K-56.5%$3.8M+22.8%$4.3M-51.6%$2.0M-77.2%$2.0M-76.7%$3.1M-71.8%$8.8M-18.7%
Current Assets$841K+22.3%$662K+947.8%$3.8M+1347.7%$4.2M+515.2%$688K+505.9%$63K-4.4%$260K-83.5%$682K+345.8%
Cash & Equivalents$719K+1743.6%$375K+1873.7%$1.8M+830.9%$3.0M+564440.3%$39K+500.4%$19K+257.5%$191K+4126.6%$533-96.9%
Short-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0-100.0%$0-100.0%$0-100.0%$0n/m
Total Liabilities$28.2M-77.7%$29.1M-76.5%$30.4M-75.1%$38.2M-69.6%$126.1M+2.5%$123.9M+2.8%$122.3M+1.2%$125.7M+780.1%
Current Liabilities$28.2M+74.1%$29.0M+118.9%$22.3M-61.0%$23.5M+355.7%$16.2M+289.2%$13.3M+234.3%$57.1M+1060.8%$5.2M+72.2%
Non-Current Liabilities$2K-100.0%$40K-100.0%$8.2M-87.5%$14.7M-87.8%$110.0M-7.5%$110.6M-5.1%$65.1M-43.8%$120.6M+968.1%
Total Equity-$27.1Mn/m-$28.2Mn/m-$26.7Mn/m-$34.0Mn/m-$124.2Mn/m-$121.9Mn/m-$119.2Mn/m-$117.0Mn/m
Retained Earnings-$173.0Mn/m-$164.2Mn/m-$160.8Mn/m-$152.2Mn/m-$22.5Mn/m-$14.3Mn/m-$125.0Mn/m-$5.2Mn/m

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.

NVACW Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NVACW quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'24S-1/AQ3'2410-Q
Operating Cash Flow-$2.6Mn/m-$2.6Mn/m-$5.1Mn/m-$10.0Mn/m-$589Kn/m-$537Kn/m-$238Kn/m-$1.2Mn/m
Stock-Based Compensation$188K+129.3%$187K+3640.0%N/A$617K+5041.7%$82K$5KN/A$12K
Capital Expenditures$73K$5KN/AN/AN/AN/AN/AN/A
Free Cash Flow-$2.7M-$2.6MN/AN/AN/AN/AN/AN/A
Investing Cash Flow-$73Kn/m$1.1M-82.4%-$1.0M-320.1%-$7.5Mn/m-$1-100.0%$6.5M+153.8%$458Kn/m-$112K-175.8%
Financing Cash Flow$3.0M+400.7%$28K-92.3%$4.9M+1597.6%$14.0M+270.3%$609K+84.1%$365Kn/m$289K-29.3%$3.8M+997.9%
Share BuybacksN/AN/AN/AN/A$0n/m$6.5M+145.4%$595Kn/m$0n/m

Not reported in any period shown, so not listed: Depreciation & Amortization, Dividends Paid.

NVACW Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NVACW quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'24S-1/AQ3'2410-Q
Operating MarginN/AN/AN/AN/AN/AN/AN/A-1470.7%
Net MarginN/AN/AN/AN/AN/AN/AN/A-3329.3%
Return on AssetsN/A-400.9%-264.0ppN/AN/A-119.6%-91.6pp-136.9%-112.5ppN/A-28.4%-25.0pp
Current Ratio0.030.0x0.020.0x0.17+0.2x0.180.0x0.040.0x0.000.0x0.00-0.3x0.13+0.1x
Asset TurnoverN/AN/AN/AN/AN/AN/AN/A0.01

Not reported in any period shown, so not listed: Gross Margin, Return on Equity, Debt-to-Equity, Liabilities-to-Equity, FCF Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.

Note: Shareholder equity is negative (-$26.7M), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.17), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

What is PROFUSA INC WTS's earnings per share (EPS)?

PROFUSA INC WTS (NVACW) reported diluted earnings per share of -$107.01 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is PROFUSA INC WTS's free cash flow?

PROFUSA INC WTS (NVACW) recorded an outflow of $16.3M in free cash flow during fiscal year 2025. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is PROFUSA INC WTS's operating cash flow?

PROFUSA INC WTS (NVACW) recorded an outflow of $16.2M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

PROFUSA INC WTS (NVACW) had $3.8M in total assets as of fiscal year 2025, including both current and long-term assets.

PROFUSA INC WTS (NVACW) invested $8K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

PROFUSA INC WTS (NVACW) invested $2.8M in research and development during fiscal year 2025.

PROFUSA INC WTS (NVACW) had 4M shares outstanding as of fiscal year 2025.

PROFUSA INC WTS (NVACW) had a current ratio of 0.17 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

PROFUSA INC WTS (NVACW) has negative shareholder equity of -$26.7M as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Back to top